Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage
- PMID: 36583354
- PMCID: PMC9799038
- DOI: 10.1097/HJH.0000000000003328
Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage
Erratum in
-
Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage: Erratum.J Hypertens. 2023 May 1;41(5):873. doi: 10.1097/HJH.0000000000003439. J Hypertens. 2023. PMID: 37017036 Free PMC article. No abstract available.
Abstract
Background: Treatment of severe inpatient hypertension (HTN) that develops during hospitalization is not informed by guidelines. Intravenous (i.v.) antihypertensives are used to manage severe HTN even in the absence of acute target organ damage; however they may result in unpredictable blood pressure (BP) reduction and cardiovascular events. Our goal was to assess the association between i.v. antihypertensives and clinical outcomes in this population.
Methods: This is a multihospital retrospective study of adults admitted for reasons other than HTN who develop severe HTN during hospitalization without acute target end organ damage. We defined severe HTN as BP elevation of systolic >180 or diastolic >110 mmHg. Treatment was defined as receiving i.v. antihypertensives within 3 h of BP elevation. We used overlap propensity score weighted Cox models to study the association between treatment and clinical outcomes during index hospitalization.
Results: Of 224 265 unique, nonintensive care unit hospitalizations, 20 383 (9%) developed severe HTN, of which 5% received i.v. antihypertensives and 79% were untreated within 3 h of severe BP elevation. In the overlap propensity weighted population, patients who received i.v. antihypertensives were more likely to develop myocardial injury (5.9% in treated versus 3.6% in untreated; hazard ratio [HR]: 1.6 [1.13, 2.24]). Treatment was not associated with increased risk of stroke (HR: 0.7 [0.3, 1.62]), acute kidney injury (HR: 0.97 [0.81, 1.17]), or death (HR: 0.86 [0.49, 1.51]).
Conclusions: Intravenous antihypertensives were associated with increased risk of myocardial injury in patients who develop severe HTN during hospitalization. These results suggest that i.v. antihypertensives should be used with caution in patients without acute target organ damage.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
There are no conflicts of interest.
Figures
Comment in
-
Intravenous antihypertensive drugs: a double-edged sword?J Hypertens. 2023 Feb 1;41(2):220-222. doi: 10.1097/HJH.0000000000003344. J Hypertens. 2023. PMID: 36583349 No abstract available.
Similar articles
-
Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment.J Clin Hypertens (Greenwich). 2022 Mar;24(3):339-349. doi: 10.1111/jch.14431. Epub 2022 Feb 17. J Clin Hypertens (Greenwich). 2022. PMID: 35174627 Free PMC article.
-
Blood pressure response to commonly administered antihypertensives for severe inpatient hypertension.PLoS One. 2022 Apr 6;17(4):e0265497. doi: 10.1371/journal.pone.0265497. eCollection 2022. PLoS One. 2022. PMID: 35385506 Free PMC article.
-
Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults.JAMA Intern Med. 2023 Jul 1;183(7):715-723. doi: 10.1001/jamainternmed.2023.1667. JAMA Intern Med. 2023. PMID: 37252732 Free PMC article.
-
Treatment of Hypertension Among Non-Cardiac Hospitalized Patients.Curr Cardiol Rep. 2022 Jul;24(7):801-805. doi: 10.1007/s11886-022-01699-0. Epub 2022 May 7. Curr Cardiol Rep. 2022. PMID: 35524879 Free PMC article. Review.
-
Proposal of a Modified Classification of Hypertensive Crises: Urgency, Impending Emergency, and Emergency.Curr Vasc Pharmacol. 2024;22(3):180-186. doi: 10.2174/0115701611270174231204110557. Curr Vasc Pharmacol. 2024. PMID: 39188222 Review.
Cited by
-
Management of Inpatient Elevated Blood Pressures : A Systematic Review of Clinical Practice Guidelines.Ann Intern Med. 2024 Apr;177(4):497-506. doi: 10.7326/M23-3251. Epub 2024 Apr 2. Ann Intern Med. 2024. PMID: 38560900 Free PMC article. Review.
References
-
- Peixoto AJ. Acute severe hypertension. N Engl J Med 2019; 381:1843–1852. - PubMed
-
- Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2018; 138:e426–e483. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
